nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Clobetasol propionate—psoriasis	0.104	0.202	CbGbCtD
Bromocriptine—CYP1A2—Methoxsalen—psoriasis	0.0545	0.106	CbGbCtD
Bromocriptine—CYP3A4—Calcitriol—psoriasis	0.0367	0.0715	CbGbCtD
Bromocriptine—CYP3A4—Methoxsalen—psoriasis	0.0285	0.0556	CbGbCtD
Bromocriptine—ABCB1—Mycophenolate mofetil—psoriasis	0.0274	0.0533	CbGbCtD
Bromocriptine—ABCB1—Betamethasone—psoriasis	0.0235	0.0458	CbGbCtD
Bromocriptine—ABCB1—Prednisolone—psoriasis	0.0232	0.0451	CbGbCtD
Bromocriptine—ABCB1—Hydrocortisone—psoriasis	0.022	0.0428	CbGbCtD
Bromocriptine—ABCB1—Prednisone—psoriasis	0.0219	0.0426	CbGbCtD
Bromocriptine—ABCB1—Cyclosporine—psoriasis	0.0207	0.0404	CbGbCtD
Bromocriptine—CYP3A4—Cholecalciferol—psoriasis	0.0189	0.0368	CbGbCtD
Bromocriptine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0164	0.0319	CbGbCtD
Bromocriptine—CYP3A4—Triamcinolone—psoriasis	0.0164	0.0319	CbGbCtD
Bromocriptine—CYP3A4—Betamethasone—psoriasis	0.0141	0.0274	CbGbCtD
Bromocriptine—CYP3A4—Prednisolone—psoriasis	0.0139	0.027	CbGbCtD
Bromocriptine—ABCB1—Dexamethasone—psoriasis	0.0137	0.0266	CbGbCtD
Bromocriptine—CYP3A4—Hydrocortisone—psoriasis	0.0132	0.0256	CbGbCtD
Bromocriptine—CYP3A4—Prednisone—psoriasis	0.0131	0.0255	CbGbCtD
Bromocriptine—CYP3A4—Cyclosporine—psoriasis	0.0124	0.0242	CbGbCtD
Bromocriptine—ABCB1—Methotrexate—psoriasis	0.011	0.0214	CbGbCtD
Bromocriptine—CYP3A4—Dexamethasone—psoriasis	0.00818	0.0159	CbGbCtD
Bromocriptine—Tachycardia—Prednisolone—psoriasis	0.000239	0.000546	CcSEcCtD
Bromocriptine—Asthenia—Mycophenolic acid—psoriasis	0.000239	0.000545	CcSEcCtD
Bromocriptine—Hypertension—Triamcinolone—psoriasis	0.000238	0.000544	CcSEcCtD
Bromocriptine—Infection—Hydrocortisone—psoriasis	0.000238	0.000543	CcSEcCtD
Bromocriptine—Insomnia—Mycophenolate mofetil—psoriasis	0.000237	0.000543	CcSEcCtD
Bromocriptine—Dyspepsia—Cyclosporine—psoriasis	0.000237	0.000541	CcSEcCtD
Bromocriptine—Nausea—Hydroxyurea—psoriasis	0.000236	0.000539	CcSEcCtD
Bromocriptine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000236	0.000539	CcSEcCtD
Bromocriptine—Shock—Hydrocortisone—psoriasis	0.000235	0.000538	CcSEcCtD
Bromocriptine—Nervous system disorder—Hydrocortisone—psoriasis	0.000234	0.000536	CcSEcCtD
Bromocriptine—Eye disorder—Prednisone—psoriasis	0.000234	0.000535	CcSEcCtD
Bromocriptine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000234	0.000535	CcSEcCtD
Bromocriptine—Decreased appetite—Cyclosporine—psoriasis	0.000234	0.000535	CcSEcCtD
Bromocriptine—Tachycardia—Hydrocortisone—psoriasis	0.000233	0.000533	CcSEcCtD
Bromocriptine—Somnolence—Mycophenolate mofetil—psoriasis	0.000233	0.000533	CcSEcCtD
Bromocriptine—Drowsiness—Methotrexate—psoriasis	0.000233	0.000533	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000232	0.000531	CcSEcCtD
Bromocriptine—Skin disorder—Hydrocortisone—psoriasis	0.000232	0.000531	CcSEcCtD
Bromocriptine—Fatigue—Cyclosporine—psoriasis	0.000232	0.00053	CcSEcCtD
Bromocriptine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000231	0.000528	CcSEcCtD
Bromocriptine—Constipation—Cyclosporine—psoriasis	0.00023	0.000526	CcSEcCtD
Bromocriptine—Dry mouth—Triamcinolone—psoriasis	0.00023	0.000525	CcSEcCtD
Bromocriptine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000228	0.000521	CcSEcCtD
Bromocriptine—Anorexia—Hydrocortisone—psoriasis	0.000228	0.000521	CcSEcCtD
Bromocriptine—Diarrhoea—Mycophenolic acid—psoriasis	0.000228	0.00052	CcSEcCtD
Bromocriptine—Angiopathy—Prednisone—psoriasis	0.000227	0.000519	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000227	0.000518	CcSEcCtD
Bromocriptine—Oedema—Triamcinolone—psoriasis	0.000225	0.000515	CcSEcCtD
Bromocriptine—Vertigo—Dexamethasone—psoriasis	0.000225	0.000514	CcSEcCtD
Bromocriptine—Vertigo—Betamethasone—psoriasis	0.000225	0.000514	CcSEcCtD
Bromocriptine—Syncope—Dexamethasone—psoriasis	0.000224	0.000513	CcSEcCtD
Bromocriptine—Syncope—Betamethasone—psoriasis	0.000224	0.000513	CcSEcCtD
Bromocriptine—Constipation—Mycophenolate mofetil—psoriasis	0.000224	0.000513	CcSEcCtD
Bromocriptine—Arrhythmia—Prednisone—psoriasis	0.000224	0.000511	CcSEcCtD
Bromocriptine—Infection—Triamcinolone—psoriasis	0.000224	0.000511	CcSEcCtD
Bromocriptine—Hypotension—Hydrocortisone—psoriasis	0.000223	0.000511	CcSEcCtD
Bromocriptine—Feeling abnormal—Cyclosporine—psoriasis	0.000222	0.000507	CcSEcCtD
Bromocriptine—Shock—Triamcinolone—psoriasis	0.000221	0.000506	CcSEcCtD
Bromocriptine—Insomnia—Prednisolone—psoriasis	0.000221	0.000506	CcSEcCtD
Bromocriptine—Alopecia—Prednisone—psoriasis	0.000221	0.000506	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Cyclosporine—psoriasis	0.00022	0.000503	CcSEcCtD
Bromocriptine—Loss of consciousness—Dexamethasone—psoriasis	0.00022	0.000503	CcSEcCtD
Bromocriptine—Loss of consciousness—Betamethasone—psoriasis	0.00022	0.000503	CcSEcCtD
Bromocriptine—Dizziness—Mycophenolic acid—psoriasis	0.00022	0.000503	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisolone—psoriasis	0.00022	0.000502	CcSEcCtD
Bromocriptine—Tachycardia—Triamcinolone—psoriasis	0.00022	0.000502	CcSEcCtD
Bromocriptine—Mental disorder—Prednisone—psoriasis	0.000219	0.000501	CcSEcCtD
Bromocriptine—Convulsion—Dexamethasone—psoriasis	0.000217	0.000496	CcSEcCtD
Bromocriptine—Convulsion—Betamethasone—psoriasis	0.000217	0.000496	CcSEcCtD
Bromocriptine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000216	0.000494	CcSEcCtD
Bromocriptine—Insomnia—Hydrocortisone—psoriasis	0.000216	0.000494	CcSEcCtD
Bromocriptine—Hypertension—Dexamethasone—psoriasis	0.000216	0.000494	CcSEcCtD
Bromocriptine—Hypertension—Betamethasone—psoriasis	0.000216	0.000494	CcSEcCtD
Bromocriptine—Paraesthesia—Hydrocortisone—psoriasis	0.000215	0.000491	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000215	0.00049	CcSEcCtD
Bromocriptine—Urticaria—Cyclosporine—psoriasis	0.000214	0.000488	CcSEcCtD
Bromocriptine—Body temperature increased—Cyclosporine—psoriasis	0.000213	0.000486	CcSEcCtD
Bromocriptine—Abdominal pain—Cyclosporine—psoriasis	0.000213	0.000486	CcSEcCtD
Bromocriptine—Anxiety—Dexamethasone—psoriasis	0.000212	0.000485	CcSEcCtD
Bromocriptine—Anxiety—Betamethasone—psoriasis	0.000212	0.000485	CcSEcCtD
Bromocriptine—Vomiting—Mycophenolic acid—psoriasis	0.000211	0.000483	CcSEcCtD
Bromocriptine—Dyspepsia—Hydrocortisone—psoriasis	0.00021	0.000481	CcSEcCtD
Bromocriptine—Rash—Mycophenolic acid—psoriasis	0.00021	0.000479	CcSEcCtD
Bromocriptine—Dermatitis—Mycophenolic acid—psoriasis	0.000209	0.000479	CcSEcCtD
Bromocriptine—Urticaria—Mycophenolate mofetil—psoriasis	0.000208	0.000477	CcSEcCtD
Bromocriptine—Headache—Mycophenolic acid—psoriasis	0.000208	0.000476	CcSEcCtD
Bromocriptine—Decreased appetite—Hydrocortisone—psoriasis	0.000208	0.000475	CcSEcCtD
Bromocriptine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000207	0.000474	CcSEcCtD
Bromocriptine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000207	0.000474	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000206	0.000472	CcSEcCtD
Bromocriptine—Fatigue—Hydrocortisone—psoriasis	0.000206	0.000471	CcSEcCtD
Bromocriptine—Vision blurred—Prednisone—psoriasis	0.000205	0.000469	CcSEcCtD
Bromocriptine—Oedema—Betamethasone—psoriasis	0.000204	0.000467	CcSEcCtD
Bromocriptine—Oedema—Dexamethasone—psoriasis	0.000204	0.000467	CcSEcCtD
Bromocriptine—Insomnia—Triamcinolone—psoriasis	0.000204	0.000465	CcSEcCtD
Bromocriptine—Infection—Dexamethasone—psoriasis	0.000203	0.000464	CcSEcCtD
Bromocriptine—Infection—Betamethasone—psoriasis	0.000203	0.000464	CcSEcCtD
Bromocriptine—Paraesthesia—Triamcinolone—psoriasis	0.000202	0.000462	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisolone—psoriasis	0.000202	0.000461	CcSEcCtD
Bromocriptine—Visual impairment—Methotrexate—psoriasis	0.000202	0.000461	CcSEcCtD
Bromocriptine—Shock—Betamethasone—psoriasis	0.000201	0.000459	CcSEcCtD
Bromocriptine—Shock—Dexamethasone—psoriasis	0.000201	0.000459	CcSEcCtD
Bromocriptine—Dyspnoea—Triamcinolone—psoriasis	0.000201	0.000459	CcSEcCtD
Bromocriptine—Nervous system disorder—Dexamethasone—psoriasis	0.0002	0.000458	CcSEcCtD
Bromocriptine—Nervous system disorder—Betamethasone—psoriasis	0.0002	0.000458	CcSEcCtD
Bromocriptine—Agitation—Prednisone—psoriasis	0.0002	0.000458	CcSEcCtD
Bromocriptine—Tachycardia—Dexamethasone—psoriasis	0.000199	0.000456	CcSEcCtD
Bromocriptine—Tachycardia—Betamethasone—psoriasis	0.000199	0.000456	CcSEcCtD
Bromocriptine—Dyspepsia—Triamcinolone—psoriasis	0.000198	0.000453	CcSEcCtD
Bromocriptine—Nausea—Mycophenolic acid—psoriasis	0.000198	0.000451	CcSEcCtD
Bromocriptine—Feeling abnormal—Hydrocortisone—psoriasis	0.000197	0.00045	CcSEcCtD
Bromocriptine—Vertigo—Prednisone—psoriasis	0.000196	0.000448	CcSEcCtD
Bromocriptine—Eye disorder—Methotrexate—psoriasis	0.000196	0.000447	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000196	0.000447	CcSEcCtD
Bromocriptine—Syncope—Prednisone—psoriasis	0.000195	0.000447	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—psoriasis	0.000195	0.000446	CcSEcCtD
Bromocriptine—Anorexia—Dexamethasone—psoriasis	0.000195	0.000445	CcSEcCtD
Bromocriptine—Anorexia—Betamethasone—psoriasis	0.000195	0.000445	CcSEcCtD
Bromocriptine—Urticaria—Prednisolone—psoriasis	0.000194	0.000444	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—psoriasis	0.000194	0.000444	CcSEcCtD
Bromocriptine—Fatigue—Triamcinolone—psoriasis	0.000194	0.000444	CcSEcCtD
Bromocriptine—Asthenia—Cyclosporine—psoriasis	0.000193	0.000441	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisone—psoriasis	0.000192	0.000438	CcSEcCtD
Bromocriptine—Hypotension—Dexamethasone—psoriasis	0.000191	0.000436	CcSEcCtD
Bromocriptine—Hypotension—Betamethasone—psoriasis	0.000191	0.000436	CcSEcCtD
Bromocriptine—Urticaria—Hydrocortisone—psoriasis	0.00019	0.000434	CcSEcCtD
Bromocriptine—Angiopathy—Methotrexate—psoriasis	0.00019	0.000434	CcSEcCtD
Bromocriptine—Abdominal pain—Hydrocortisone—psoriasis	0.000189	0.000432	CcSEcCtD
Bromocriptine—Body temperature increased—Hydrocortisone—psoriasis	0.000189	0.000432	CcSEcCtD
Bromocriptine—Convulsion—Prednisone—psoriasis	0.000189	0.000432	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—psoriasis	0.000189	0.000431	CcSEcCtD
Bromocriptine—Asthenia—Mycophenolate mofetil—psoriasis	0.000188	0.00043	CcSEcCtD
Bromocriptine—Hypertension—Prednisone—psoriasis	0.000188	0.00043	CcSEcCtD
Bromocriptine—Feeling abnormal—Triamcinolone—psoriasis	0.000186	0.000424	CcSEcCtD
Bromocriptine—Anxiety—Prednisone—psoriasis	0.000185	0.000423	CcSEcCtD
Bromocriptine—Alopecia—Methotrexate—psoriasis	0.000185	0.000423	CcSEcCtD
Bromocriptine—Insomnia—Dexamethasone—psoriasis	0.000185	0.000422	CcSEcCtD
Bromocriptine—Insomnia—Betamethasone—psoriasis	0.000185	0.000422	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000184	0.000421	CcSEcCtD
Bromocriptine—Diarrhoea—Cyclosporine—psoriasis	0.000184	0.000421	CcSEcCtD
Bromocriptine—Paraesthesia—Betamethasone—psoriasis	0.000183	0.000419	CcSEcCtD
Bromocriptine—Paraesthesia—Dexamethasone—psoriasis	0.000183	0.000419	CcSEcCtD
Bromocriptine—Mental disorder—Methotrexate—psoriasis	0.000183	0.000419	CcSEcCtD
Bromocriptine—Dyspepsia—Dexamethasone—psoriasis	0.00018	0.000411	CcSEcCtD
Bromocriptine—Dyspepsia—Betamethasone—psoriasis	0.00018	0.000411	CcSEcCtD
Bromocriptine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.00018	0.00041	CcSEcCtD
Bromocriptine—Urticaria—Triamcinolone—psoriasis	0.000179	0.000409	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—psoriasis	0.000178	0.000408	CcSEcCtD
Bromocriptine—Body temperature increased—Triamcinolone—psoriasis	0.000178	0.000407	CcSEcCtD
Bromocriptine—Dizziness—Cyclosporine—psoriasis	0.000178	0.000407	CcSEcCtD
Bromocriptine—Oedema—Prednisone—psoriasis	0.000178	0.000407	CcSEcCtD
Bromocriptine—Decreased appetite—Betamethasone—psoriasis	0.000178	0.000406	CcSEcCtD
Bromocriptine—Decreased appetite—Dexamethasone—psoriasis	0.000178	0.000406	CcSEcCtD
Bromocriptine—Infection—Prednisone—psoriasis	0.000177	0.000404	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000176	0.000403	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000176	0.000403	CcSEcCtD
Bromocriptine—Fatigue—Betamethasone—psoriasis	0.000176	0.000403	CcSEcCtD
Bromocriptine—Fatigue—Dexamethasone—psoriasis	0.000176	0.000403	CcSEcCtD
Bromocriptine—Shock—Prednisone—psoriasis	0.000175	0.0004	CcSEcCtD
Bromocriptine—Nervous system disorder—Prednisone—psoriasis	0.000174	0.000399	CcSEcCtD
Bromocriptine—Tachycardia—Prednisone—psoriasis	0.000174	0.000397	CcSEcCtD
Bromocriptine—Dizziness—Mycophenolate mofetil—psoriasis	0.000174	0.000397	CcSEcCtD
Bromocriptine—Skin disorder—Prednisone—psoriasis	0.000173	0.000395	CcSEcCtD
Bromocriptine—Vision blurred—Methotrexate—psoriasis	0.000172	0.000392	CcSEcCtD
Bromocriptine—Asthenia—Hydrocortisone—psoriasis	0.000172	0.000392	CcSEcCtD
Bromocriptine—Vomiting—Cyclosporine—psoriasis	0.000171	0.000391	CcSEcCtD
Bromocriptine—Rash—Cyclosporine—psoriasis	0.00017	0.000388	CcSEcCtD
Bromocriptine—Anorexia—Prednisone—psoriasis	0.00017	0.000388	CcSEcCtD
Bromocriptine—Dermatitis—Cyclosporine—psoriasis	0.000169	0.000387	CcSEcCtD
Bromocriptine—Headache—Cyclosporine—psoriasis	0.000169	0.000385	CcSEcCtD
Bromocriptine—Feeling abnormal—Dexamethasone—psoriasis	0.000168	0.000385	CcSEcCtD
Bromocriptine—Feeling abnormal—Betamethasone—psoriasis	0.000168	0.000385	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Betamethasone—psoriasis	0.000167	0.000382	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000167	0.000382	CcSEcCtD
Bromocriptine—Vomiting—Mycophenolate mofetil—psoriasis	0.000167	0.000381	CcSEcCtD
Bromocriptine—Rash—Mycophenolate mofetil—psoriasis	0.000165	0.000378	CcSEcCtD
Bromocriptine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000165	0.000378	CcSEcCtD
Bromocriptine—Headache—Mycophenolate mofetil—psoriasis	0.000164	0.000376	CcSEcCtD
Bromocriptine—Vertigo—Methotrexate—psoriasis	0.000164	0.000374	CcSEcCtD
Bromocriptine—Diarrhoea—Hydrocortisone—psoriasis	0.000164	0.000374	CcSEcCtD
Bromocriptine—Urticaria—Betamethasone—psoriasis	0.000162	0.000371	CcSEcCtD
Bromocriptine—Urticaria—Dexamethasone—psoriasis	0.000162	0.000371	CcSEcCtD
Bromocriptine—Dizziness—Prednisolone—psoriasis	0.000162	0.00037	CcSEcCtD
Bromocriptine—Asthenia—Triamcinolone—psoriasis	0.000162	0.000369	CcSEcCtD
Bromocriptine—Abdominal pain—Betamethasone—psoriasis	0.000161	0.000369	CcSEcCtD
Bromocriptine—Abdominal pain—Dexamethasone—psoriasis	0.000161	0.000369	CcSEcCtD
Bromocriptine—Body temperature increased—Betamethasone—psoriasis	0.000161	0.000369	CcSEcCtD
Bromocriptine—Body temperature increased—Dexamethasone—psoriasis	0.000161	0.000369	CcSEcCtD
Bromocriptine—Insomnia—Prednisone—psoriasis	0.000161	0.000368	CcSEcCtD
Bromocriptine—Nausea—Cyclosporine—psoriasis	0.00016	0.000365	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisone—psoriasis	0.00016	0.000365	CcSEcCtD
Bromocriptine—Dizziness—Hydrocortisone—psoriasis	0.000158	0.000361	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—psoriasis	0.000158	0.000361	CcSEcCtD
Bromocriptine—Dyspepsia—Prednisone—psoriasis	0.000157	0.000358	CcSEcCtD
Bromocriptine—Nausea—Mycophenolate mofetil—psoriasis	0.000156	0.000356	CcSEcCtD
Bromocriptine—Decreased appetite—Prednisone—psoriasis	0.000155	0.000353	CcSEcCtD
Bromocriptine—Rash—Prednisolone—psoriasis	0.000154	0.000353	CcSEcCtD
Bromocriptine—Dermatitis—Prednisolone—psoriasis	0.000154	0.000352	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000154	0.000352	CcSEcCtD
Bromocriptine—Fatigue—Prednisone—psoriasis	0.000153	0.000351	CcSEcCtD
Bromocriptine—Headache—Prednisolone—psoriasis	0.000153	0.000351	CcSEcCtD
Bromocriptine—Constipation—Prednisone—psoriasis	0.000152	0.000348	CcSEcCtD
Bromocriptine—Vomiting—Hydrocortisone—psoriasis	0.000152	0.000347	CcSEcCtD
Bromocriptine—Rash—Hydrocortisone—psoriasis	0.000151	0.000345	CcSEcCtD
Bromocriptine—Dermatitis—Hydrocortisone—psoriasis	0.000151	0.000344	CcSEcCtD
Bromocriptine—Confusional state—Methotrexate—psoriasis	0.00015	0.000343	CcSEcCtD
Bromocriptine—Headache—Hydrocortisone—psoriasis	0.00015	0.000342	CcSEcCtD
Bromocriptine—Dizziness—Triamcinolone—psoriasis	0.000149	0.00034	CcSEcCtD
Bromocriptine—Infection—Methotrexate—psoriasis	0.000148	0.000338	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisone—psoriasis	0.000147	0.000335	CcSEcCtD
Bromocriptine—Asthenia—Dexamethasone—psoriasis	0.000147	0.000335	CcSEcCtD
Bromocriptine—Asthenia—Betamethasone—psoriasis	0.000147	0.000335	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—psoriasis	0.000146	0.000333	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Prednisone—psoriasis	0.000145	0.000332	CcSEcCtD
Bromocriptine—Nausea—Prednisolone—psoriasis	0.000145	0.000332	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—psoriasis	0.000144	0.00033	CcSEcCtD
Bromocriptine—Vomiting—Triamcinolone—psoriasis	0.000143	0.000327	CcSEcCtD
Bromocriptine—Nausea—Hydrocortisone—psoriasis	0.000142	0.000325	CcSEcCtD
Bromocriptine—Rash—Triamcinolone—psoriasis	0.000142	0.000324	CcSEcCtD
Bromocriptine—Dermatitis—Triamcinolone—psoriasis	0.000142	0.000324	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—psoriasis	0.000142	0.000324	CcSEcCtD
Bromocriptine—Urticaria—Prednisone—psoriasis	0.000141	0.000323	CcSEcCtD
Bromocriptine—Headache—Triamcinolone—psoriasis	0.000141	0.000322	CcSEcCtD
Bromocriptine—Body temperature increased—Prednisone—psoriasis	0.000141	0.000321	CcSEcCtD
Bromocriptine—Abdominal pain—Prednisone—psoriasis	0.000141	0.000321	CcSEcCtD
Bromocriptine—Diarrhoea—Dexamethasone—psoriasis	0.00014	0.000319	CcSEcCtD
Bromocriptine—Diarrhoea—Betamethasone—psoriasis	0.00014	0.000319	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—psoriasis	0.000139	0.000318	CcSEcCtD
Bromocriptine—Dizziness—Dexamethasone—psoriasis	0.000135	0.000309	CcSEcCtD
Bromocriptine—Dizziness—Betamethasone—psoriasis	0.000135	0.000309	CcSEcCtD
Bromocriptine—Insomnia—Methotrexate—psoriasis	0.000134	0.000307	CcSEcCtD
Bromocriptine—Nausea—Triamcinolone—psoriasis	0.000134	0.000306	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—psoriasis	0.000133	0.000305	CcSEcCtD
Bromocriptine—Dyspnoea—Methotrexate—psoriasis	0.000133	0.000303	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—psoriasis	0.000132	0.000302	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—psoriasis	0.000131	0.000299	CcSEcCtD
Bromocriptine—Vomiting—Dexamethasone—psoriasis	0.00013	0.000297	CcSEcCtD
Bromocriptine—Vomiting—Betamethasone—psoriasis	0.00013	0.000297	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—psoriasis	0.000129	0.000295	CcSEcCtD
Bromocriptine—Rash—Dexamethasone—psoriasis	0.000129	0.000294	CcSEcCtD
Bromocriptine—Rash—Betamethasone—psoriasis	0.000129	0.000294	CcSEcCtD
Bromocriptine—Dermatitis—Dexamethasone—psoriasis	0.000129	0.000294	CcSEcCtD
Bromocriptine—Dermatitis—Betamethasone—psoriasis	0.000129	0.000294	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000128	0.000293	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—psoriasis	0.000128	0.000293	CcSEcCtD
Bromocriptine—Headache—Dexamethasone—psoriasis	0.000128	0.000292	CcSEcCtD
Bromocriptine—Headache—Betamethasone—psoriasis	0.000128	0.000292	CcSEcCtD
Bromocriptine—Asthenia—Prednisone—psoriasis	0.000128	0.000292	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—psoriasis	0.000123	0.00028	CcSEcCtD
Bromocriptine—Diarrhoea—Prednisone—psoriasis	0.000122	0.000278	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—psoriasis	0.000122	0.000278	CcSEcCtD
Bromocriptine—Nausea—Dexamethasone—psoriasis	0.000121	0.000277	CcSEcCtD
Bromocriptine—Nausea—Betamethasone—psoriasis	0.000121	0.000277	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—psoriasis	0.000118	0.00027	CcSEcCtD
Bromocriptine—Dizziness—Prednisone—psoriasis	0.000118	0.000269	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—psoriasis	0.000118	0.000269	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—psoriasis	0.000118	0.000269	CcSEcCtD
Bromocriptine—Vomiting—Prednisone—psoriasis	0.000113	0.000259	CcSEcCtD
Bromocriptine—Rash—Prednisone—psoriasis	0.000112	0.000256	CcSEcCtD
Bromocriptine—Dermatitis—Prednisone—psoriasis	0.000112	0.000256	CcSEcCtD
Bromocriptine—Headache—Prednisone—psoriasis	0.000111	0.000255	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—psoriasis	0.000107	0.000244	CcSEcCtD
Bromocriptine—Nausea—Prednisone—psoriasis	0.000106	0.000242	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—psoriasis	0.000102	0.000232	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—psoriasis	9.83e-05	0.000225	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—psoriasis	9.45e-05	0.000216	CcSEcCtD
Bromocriptine—Rash—Methotrexate—psoriasis	9.37e-05	0.000214	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—psoriasis	9.36e-05	0.000214	CcSEcCtD
Bromocriptine—Headache—Methotrexate—psoriasis	9.31e-05	0.000213	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—psoriasis	8.83e-05	0.000202	CcSEcCtD
Bromocriptine—HTR2B—Signaling Pathways—NFKBIA—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—LEP—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—APOE—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—APOE—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—LEP—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.26e-05	0.000255	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.24e-05	0.000252	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.23e-05	0.00025	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.23e-05	0.000249	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.22e-05	0.000248	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—IL6—psoriasis	1.21e-05	0.000246	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.2e-05	0.000243	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	1.19e-05	0.000242	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.19e-05	0.000242	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CARM1—psoriasis	1.19e-05	0.000241	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NFKBIA—psoriasis	1.19e-05	0.000241	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—JUN—psoriasis	1.19e-05	0.00024	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.17e-05	0.000238	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.17e-05	0.000238	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	1.17e-05	0.000238	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NFKBIA—psoriasis	1.17e-05	0.000238	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.17e-05	0.000237	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.15e-05	0.000233	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—APOE—psoriasis	1.15e-05	0.000232	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—LEP—psoriasis	1.15e-05	0.000232	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—NFKB1—psoriasis	1.14e-05	0.000231	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—APOE—psoriasis	1.14e-05	0.00023	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—LEP—psoriasis	1.14e-05	0.00023	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TYK2—psoriasis	1.13e-05	0.000229	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TYK2—psoriasis	1.13e-05	0.000229	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TYK2—psoriasis	1.12e-05	0.000227	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.11e-05	0.000226	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.11e-05	0.000226	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PPARG—psoriasis	1.1e-05	0.000224	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TYK2—psoriasis	1.1e-05	0.000223	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—APOE—psoriasis	1.1e-05	0.000222	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—LEP—psoriasis	1.1e-05	0.000222	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—LEP—psoriasis	1.09e-05	0.000221	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—APOE—psoriasis	1.09e-05	0.000221	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.08e-05	0.00022	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TYK2—psoriasis	1.08e-05	0.000219	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.000217	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.07e-05	0.000216	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.07e-05	0.000216	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—LEP—psoriasis	1.06e-05	0.000215	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—APOE—psoriasis	1.06e-05	0.000215	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	1.06e-05	0.000215	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—APOE—psoriasis	1.04e-05	0.000212	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—LEP—psoriasis	1.04e-05	0.000212	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	1.04e-05	0.000212	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TP53—psoriasis	1.04e-05	0.00021	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—VEGFA—psoriasis	1.04e-05	0.00021	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TYK2—psoriasis	1.03e-05	0.000209	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—APOE—psoriasis	1.03e-05	0.000209	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—STAT3—psoriasis	1.03e-05	0.000208	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.02e-05	0.000207	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.02e-05	0.000206	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	9.88e-06	0.0002	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CXCL8—psoriasis	9.84e-06	0.0002	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CXCL8—psoriasis	9.83e-06	0.000199	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CXCL8—psoriasis	9.77e-06	0.000198	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TYK2—psoriasis	9.73e-06	0.000197	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	9.73e-06	0.000197	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	9.69e-06	0.000197	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—LEP—psoriasis	9.62e-06	0.000195	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—APOE—psoriasis	9.62e-06	0.000195	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TYK2—psoriasis	9.6e-06	0.000195	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TYK2—psoriasis	9.6e-06	0.000195	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CXCL8—psoriasis	9.56e-06	0.000194	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—LEP—psoriasis	9.47e-06	0.000192	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—APOE—psoriasis	9.47e-06	0.000192	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CXCL8—psoriasis	9.41e-06	0.000191	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—psoriasis	9.36e-06	0.00019	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—psoriasis	9.35e-06	0.00019	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—psoriasis	9.29e-06	0.000188	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—APOE—psoriasis	9.27e-06	0.000188	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—LEP—psoriasis	9.27e-06	0.000188	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CARM1—psoriasis	9.18e-06	0.000186	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CAT—psoriasis	9.17e-06	0.000186	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—JUN—psoriasis	9.15e-06	0.000186	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—JUN—psoriasis	9.14e-06	0.000185	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—psoriasis	9.09e-06	0.000184	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—JUN—psoriasis	9.08e-06	0.000184	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CXCL8—psoriasis	8.98e-06	0.000182	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PPARG—psoriasis	8.97e-06	0.000182	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NFKBIA—psoriasis	8.97e-06	0.000182	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—psoriasis	8.95e-06	0.000181	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—JUN—psoriasis	8.89e-06	0.00018	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	8.82e-06	0.000179	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—NFKB1—psoriasis	8.81e-06	0.000179	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—NFKB1—psoriasis	8.8e-06	0.000178	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—JUN—psoriasis	8.75e-06	0.000177	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TYK2—psoriasis	8.75e-06	0.000177	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—NFKB1—psoriasis	8.74e-06	0.000177	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TYK2—psoriasis	8.67e-06	0.000176	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	8.64e-06	0.000175	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—APOE—psoriasis	8.61e-06	0.000175	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—LEP—psoriasis	8.61e-06	0.000175	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—NFKB1—psoriasis	8.56e-06	0.000174	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—psoriasis	8.54e-06	0.000173	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCL8—psoriasis	8.47e-06	0.000172	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NFKB1—psoriasis	8.42e-06	0.000171	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TYK2—psoriasis	8.37e-06	0.00017	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	8.36e-06	0.00017	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCL8—psoriasis	8.36e-06	0.00017	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—JUN—psoriasis	8.35e-06	0.000169	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TYK2—psoriasis	8.32e-06	0.000169	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TYK2—psoriasis	8.09e-06	0.000164	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—psoriasis	8.05e-06	0.000163	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NFKB1—psoriasis	8.04e-06	0.000163	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	8.03e-06	0.000163	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—VEGFA—psoriasis	7.99e-06	0.000162	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—VEGFA—psoriasis	7.98e-06	0.000162	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TYK2—psoriasis	7.97e-06	0.000162	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—psoriasis	7.95e-06	0.000161	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—psoriasis	7.95e-06	0.000161	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—VEGFA—psoriasis	7.93e-06	0.000161	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—STAT3—psoriasis	7.91e-06	0.000161	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—STAT3—psoriasis	7.9e-06	0.00016	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—JUN—psoriasis	7.87e-06	0.00016	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—STAT3—psoriasis	7.85e-06	0.000159	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—psoriasis	7.82e-06	0.000159	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—JUN—psoriasis	7.77e-06	0.000158	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—JUN—psoriasis	7.77e-06	0.000158	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—VEGFA—psoriasis	7.77e-06	0.000158	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—STAT3—psoriasis	7.69e-06	0.000156	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—VEGFA—psoriasis	7.64e-06	0.000155	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCL8—psoriasis	7.61e-06	0.000154	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NFKB1—psoriasis	7.58e-06	0.000154	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—STAT3—psoriasis	7.57e-06	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	7.55e-06	0.000153	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	7.48e-06	0.000152	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NFKB1—psoriasis	7.48e-06	0.000152	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TYK2—psoriasis	7.35e-06	0.000149	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CAT—psoriasis	7.32e-06	0.000148	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—VEGFA—psoriasis	7.3e-06	0.000148	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL8—psoriasis	7.28e-06	0.000148	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL8—psoriasis	7.25e-06	0.000147	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—psoriasis	7.24e-06	0.000147	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TYK2—psoriasis	7.23e-06	0.000147	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—STAT3—psoriasis	7.22e-06	0.000147	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—psoriasis	7.17e-06	0.000146	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—psoriasis	7.16e-06	0.000145	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOE—psoriasis	7.12e-06	0.000144	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—JUN—psoriasis	7.08e-06	0.000144	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TYK2—psoriasis	7.08e-06	0.000144	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	7.05e-06	0.000143	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—JUN—psoriasis	7.01e-06	0.000142	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	6.94e-06	0.000141	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—psoriasis	6.93e-06	0.00014	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—psoriasis	6.89e-06	0.00014	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—VEGFA—psoriasis	6.88e-06	0.00014	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NFKB1—psoriasis	6.81e-06	0.000138	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—psoriasis	6.81e-06	0.000138	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	6.79e-06	0.000138	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—VEGFA—psoriasis	6.79e-06	0.000138	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—JUN—psoriasis	6.77e-06	0.000137	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	6.75e-06	0.000137	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—JUN—psoriasis	6.74e-06	0.000137	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—psoriasis	6.72e-06	0.000136	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—psoriasis	6.72e-06	0.000136	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—psoriasis	6.7e-06	0.000136	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—psoriasis	6.6e-06	0.000134	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TYK2—psoriasis	6.58e-06	0.000133	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—JUN—psoriasis	6.55e-06	0.000133	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NFKB1—psoriasis	6.52e-06	0.000132	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NFKB1—psoriasis	6.48e-06	0.000132	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—JUN—psoriasis	6.45e-06	0.000131	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL8—psoriasis	6.4e-06	0.00013	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	6.31e-06	0.000128	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL8—psoriasis	6.29e-06	0.000128	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	6.21e-06	0.000126	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARG—psoriasis	6.21e-06	0.000126	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—psoriasis	6.18e-06	0.000125	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	6.16e-06	0.000125	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	6.13e-06	0.000124	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—psoriasis	6.12e-06	0.000124	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—psoriasis	6.08e-06	0.000123	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—psoriasis	6.07e-06	0.000123	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—psoriasis	6.04e-06	0.000122	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—psoriasis	6.03e-06	0.000122	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—psoriasis	5.99e-06	0.000122	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—psoriasis	5.98e-06	0.000121	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—psoriasis	5.95e-06	0.000121	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.92e-06	0.00012	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.89e-06	0.000119	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—psoriasis	5.87e-06	0.000119	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.86e-06	0.000119	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—psoriasis	5.86e-06	0.000119	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—psoriasis	5.85e-06	0.000119	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—psoriasis	5.83e-06	0.000118	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—psoriasis	5.77e-06	0.000117	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—psoriasis	5.73e-06	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	5.72e-06	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	5.72e-06	0.000116	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NFKB1—psoriasis	5.72e-06	0.000116	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—psoriasis	5.69e-06	0.000115	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—psoriasis	5.67e-06	0.000115	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAT—psoriasis	5.65e-06	0.000115	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.63e-06	0.000114	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.63e-06	0.000114	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—psoriasis	5.58e-06	0.000113	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—psoriasis	5.53e-06	0.000112	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—psoriasis	5.52e-06	0.000112	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	5.51e-06	0.000112	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—psoriasis	5.51e-06	0.000112	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—psoriasis	5.49e-06	0.000111	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—psoriasis	5.44e-06	0.00011	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—psoriasis	5.37e-06	0.000109	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—psoriasis	5.32e-06	0.000108	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—psoriasis	5.29e-06	0.000107	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—psoriasis	5.2e-06	0.000105	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—psoriasis	5.19e-06	0.000105	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—psoriasis	5.14e-06	0.000104	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—psoriasis	5.13e-06	0.000104	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—psoriasis	5.13e-06	0.000104	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	5.12e-06	0.000104	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.11e-06	0.000104	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—psoriasis	5.06e-06	0.000103	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—psoriasis	5.05e-06	0.000102	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	5e-06	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.96e-06	0.000101	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—psoriasis	4.95e-06	0.0001	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—psoriasis	4.76e-06	9.65e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—psoriasis	4.69e-06	9.52e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—psoriasis	4.69e-06	9.52e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—psoriasis	4.67e-06	9.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	4.65e-06	9.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—psoriasis	4.63e-06	9.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—psoriasis	4.6e-06	9.34e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—psoriasis	4.47e-06	9.07e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—psoriasis	4.45e-06	9.02e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—psoriasis	4.39e-06	8.9e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—psoriasis	4.33e-06	8.77e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—psoriasis	4.28e-06	8.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—psoriasis	4.26e-06	8.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—psoriasis	4.24e-06	8.6e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—psoriasis	4.09e-06	8.3e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—psoriasis	4.07e-06	8.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—psoriasis	3.96e-06	8.03e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—psoriasis	3.92e-06	7.96e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—psoriasis	3.9e-06	7.9e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—psoriasis	3.86e-06	7.83e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—psoriasis	3.82e-06	7.75e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.78e-06	7.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—psoriasis	3.59e-06	7.29e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—psoriasis	3.53e-06	7.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—psoriasis	3.51e-06	7.13e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—psoriasis	3.46e-06	7.02e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—psoriasis	3.22e-06	6.52e-05	CbGpPWpGaD
